CHM 5.56% 1.9¢ chimeric therapeutics limited

Ann: 1st patient treated in ADVENT-AML Phase 1b clinical trial, page-23

  1. 387 Posts.
    lightbulb Created with Sketch. 76
    Cr washing done. Grind back up from here before a breakout. Glad this was one of the best opportunities to accumulate in our lifetime of investing. Gonna be a sweet ride
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.